Retinal Ischemia Characterization in Diabetes - "RICHARD"

NCT05112445 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2026-05-06

No results posted yet for this study

Summary

Retinal ischemia characterization in diabetes - RICHARD

Conditions

Sponsors & Collaborators

  • Boehringer Ingelheim

    collaborator INDUSTRY
  • Association for Innovation and Biomedical Research on Light and Image

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-03-30
Primary Completion
2025-04-30
Completion
2025-04-30

Countries

  • Portugal

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05112445 on ClinicalTrials.gov